Displaying drugs 126 - 150 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Efbemalenograstim alfa | Not Available |  | A granulocyte-colony stimulating factor used to treat prevent chemotherapy-induced neutropenia. | Colony-Stimulating Factors |
| Efgartigimod alfa | 54000.0 | | A neonatal Fc receptor blocker used to treat generalized myasthenia gravis in patients who are AChR-antibody positive. | Selective Immunosuppressants |
| Eflapegrastim | 72000.0 | | A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy. | Amino Acids, Peptides, and Proteins / Biological Factors / Blood Proteins / Carbohydrates / Colony-Stimulating Factors / Cytokines / Globulins / Glycoconjugates / Glycoproteins / Granulocyte Colony-Stimulating Factors / Hematopoietic Cell Growth Factors / Immunoglobulin Constant Regions / Immunoglobulin Fragments / Immunoglobulins / Immunoproteins / Intercellular Signaling Peptides and Proteins / Leukocyte Growth Factor / Peptide Fragments / Peptides / Proteins / Serum Globulins |
| Efmoroctocog alfa | 220000.0 C9736H14863N2591O2855S78 | | A recombinant Factor VIII used to treat and prevent bleeding in hemophilia A. | Hemostatics / Human Antihemophilic Factors |
| Eftrenonacog alfa | 98000.0 | | A recombinant Factor IX used to treat and prevent bleeding in hemophilia B. | Amino Acids, Peptides, and Proteins / Biological Factors / Blood Coagulation Factors / Blood Proteins / Enzyme Precursors / Enzymes and Coenzymes / Globulins / Hemostatics / Immunoglobulin Constant Regions / Immunoglobulin Fragments / Immunoglobulins / Immunoproteins / Peptide Fragments / Peptides / Protein Precursors / Proteins / Recombinant Proteins / Serum Globulins |
| Elapegademase | 115000.0 C1797H2795N477O544S12 | | A recombinant adenosine deaminase used to treat adenosine deaminase severe combined immune deficiency. | Adenosine Deaminase Inhibitors |
| Elosulfase alfa | 110800.0 C5020H7588N1364O1418S34 |  | A lysosomal glycosaminoglycan (GAG)-specific enzyme indicated as an enzyme replacement therapy for Mucopolysaccharidosis type IV A. | Enzymes / Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme / Polysaccharide-Lyases / Recombinant Proteins / Sulfatases |
| Elotuzumab | 148100.0 C6476H9982N1714O2016S42 |  | An antineoplastic agent and SLAMF7-directed immunostimulatory antibody used for the treatment of refractory multiple myeloma in combination with other antineoplastic agents. | Antibodies, Monoclonal |
| Elranatamab | 148500.0 C6440H9958N1738O2010S49 | | A bispecific antibody used to treat adults with relapsed or refractory multiple myeloma. | Amino Acids, Peptides, and Proteins / Antibodies, Monoclonal / Bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager / Bispecific Monoclonal Antibodies / Blood Proteins / Immunoglobulins / Proteins / Serum Globulins |
| Emapalumab | 154400.0 C6430H9898N1718O2038S46 | | An interferon gamma blocking antibody used to treat primary hemophagocytic lymphohistiocytosis. | Selective Immunosuppressants |
| Emicizumab | 145637.0 C6434-H9940-N1724-O2047-S45 |  | An antibody against Factor IXa and Factor X used to treat hemophilia A. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antihemorrhagic Agents, Miscellaneous / Blood and Blood Forming Organs / Blood Coagulation Factors / Blood Proteins / Globulins / Hemostatics / Immunoglobulins / Immunoproteins / Proteins / Serum Globulins |
| Enfortumab vedotin | 152000.0 | | An antibody-drug conjugate comprised of a fully human monoclonal antibody and microtubule-disrupting chemotherapeutic agent used in the treatment of advanced or metastatic urothelial cancer. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antibody-drug Conjugates / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Blood Proteins / Cancer immunotherapy / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Globulins / Immunoglobulins / Immunoproteins / Immunotherapy / Microtubule Inhibitors / MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES / Nectin-4-directed Antibodies / P-glycoprotein substrates / Proteins / Serum Globulins |
| Enfuvirtide | 4491.876 C204H301N51O64 |  | An HIV-1 gp41 fusion inhibitor used in patients experiencing HIV-1 replication who are already being treated with other anti-retrovirals. | HIV Envelope Protein gp41 / HIV Fusion Inhibitors / Human Immunodeficiency Virus 1 Fusion Inhibitor / Peptide Fragments |
| Epcoritamab | 149000.0 C6471H9999N1735O2007S44 | | A bispecific CD20-directed CD3 T-cell engager used to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in adults. | Amino Acids, Peptides, and Proteins / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antineoplastic Agents / Bispecific Monoclonal Antibodies / Blood Proteins / Cancer immunotherapy / CD20-directed Antibody Interactions / CD3-directed Antibody Interactions / Immunoglobulins / Immunotherapy / Increased Cytokine Production / Proteins / Serum Globulins |
| Epoetin delta | Not Annotated | | Epoetin Delta is an ingredient in the EMA-withdrawn product Dynepo. | Amino Acids, Peptides, and Proteins / Biological Factors / Carbohydrates / Colony-Stimulating Factors / Cytokines / Glycoconjugates / Glycoproteins / Hematopoietic Cell Growth Factors / Intercellular Signaling Peptides and Proteins / Peptides / Proteins |
| Eptifibatide | 831.962 C35H49N11O9S2 | | A peptide-based antagonist for glycoprotein IIb/IIIa used in the medical management of myocardial infarction and as an adjunct to percutaneous coronary intervention. | Platelet Aggregation Inhibitors Excl. Heparin |
| Eptinezumab | 143000.0 | | A monoclonal antibody directed against CGRP infused every 3 months for the preventive treatment of migraine in adults. | Calcitonin Gene-related Peptide Antagonist |
| Eptotermin alfa | Not Annotated | | A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Eptotermin alfa is an ingredient in... | Bone Morphogenetic Proteins |
| Equine Botulinum Neurotoxin A Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin B Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin C Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin D Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin E Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin F Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin G Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
Displaying drugs 126 - 150 of 406 in total